You searched for "MRI"
My Top Five: Ophthalmology TikTok accounts, educating and entertaining both the public and trainees
5 April 2022
| Umar Ahmed
|
EYE - General
In the modern world, our electronic devices have now become an extension of ourselves, with our reliance and use of them of comparable importance to an arm or a leg. The importance of electronic devices can also be seen in...
My Top Five: Ophthalmology TikTok accounts, educating and entertaining both the public and trainees
5 April 2022
| Umar Ahmed
|
EYE - General
In the modern world, our electronic devices have now become an extension of ourselves, with our reliance and use of them of comparable importance to an arm or a leg. The importance of electronic devices can also be seen in...
Immunoglobulin G4-related ophthalmic disease – what is it? (Part 1)
3 February 2023
| Li Yen Goh
|
EYE - General
Part 1: Epidemiology, classification, radiology, histopathology and associations (see Part 2 here) In this two-part series, Li Yen Goh reviews IgG4 disease and reminds us of diagnostic challenges faced. Introduction Immunoglobulin G4 (IgG4) disease is a recently recognised idiopathic systemic...
Humanitarian aid for World Optometry Day
28 March 2025
|
SpaMedica, Lions Club International, Charity, aid, Global Eye Health, World Optometry Day, industry
Lions Clubs International, a charity dedicated to providing humanitarian aid across the world, is thanking SpaMedica hospitals for their support with improving global eye health this World Optometry Day. World Optometry Day took place on Sunday 23rd March, with the...
Biotech Healthcare Successfully Concludes Global Phakic Users Meeting 2024 in Barcelona
14 October 2024
|
Company Profiles, Awards, Conferences & Anniversaries
October 3, 2024 – Celebrating its 25th anniversary, Biotech Healthcare hosted the Global Phakic Users Meeting 2024 at the stunning Joan Miró Foundation in Barcelona on 5th September. Bringing together over 150 ophthalmologists from 28 countries, the event showcased Biotech's...
‘Agenda-setting’ BCLA Clinical Conference to shape the future of contact lens practice around the world
The global eye care professional network’s “unquenchable thirst for learning” ensured the success of the first in-person BCLA Clinical Conference & Exhibition in four years.Supporting optical professions throughout the pandemic
1 December 2020
A letter has been released to go to all optical professionals on behalf of the professional bodies and government bodies responsible for ophthalmic dispensing and optometry.
Acute dellen formation post trauma
1 January 2016
| Lucia Derriman, Andrew Pearson
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Corneal dellen are saucer-like thinnings, usually of the peripheral cornea [1]. Dellen formation is thought to be related to localised tear film instability [2], specifically the absence of the mucin component of the tear film. Without the mucin layer, dry...
Moorfields to start new retinal detachment clinical trial
8 November 2023
|
Moorfields, Funding, Phase I trial, Mahi Muqit, retinal detachment, proliferative vitreoretinopathy
Moorfields to start new retinal detachment clinical trial following £1.2 million MRC DPFS grant awarded to UCL and Moorfields Eye Hospital.
Retinoblastoma management update (part 1): clinical features, diagnosis and genetics
1 January 2017
| Manoj V Parulekar
|
EYE - Oncology
The first of a two part series, this article will discuss the clinical features, diagnosis and genetic aspects of retinoblastoma. Manoj Parulekar is based at Birmingham Children’s Hospital, one of the two designated national retinoblastoma and paediatric ocular oncology treatment...
End stage glaucoma management
1 August 2014
| Yajati K Ghosh
|
EYE - Glaucoma
A 48-year-old female has had multiple drug treatment for glaucoma and is still losing field of vision. How do you manage this over time? This patient is at high-risk for going blind and should be managed aggressively to protect remaining...
